about
Cardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse ModelsRegulation of CaMKII signaling in cardiovascular diseaseArresting a transient receptor potential (TRP) channel: beta-arrestin 1 mediates ubiquitination and functional down-regulation of TRPV4GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in miceViagra for your synapses: Enhancement of hippocampal long-term potentiation by activation of beta-adrenergic receptors.Differences in the signaling pathways of α(1A)- and α(1B)-adrenoceptors are related to different endosomal targetingβ-Arrestin-biased signaling mediates memory reconsolidation.Two serines in the distal C-terminus of the human ß1-adrenoceptor determine ß-arrestin2 recruitment.Agonist binding to β-adrenergic receptors on human airway epithelial cells inhibits migration and wound repair.β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunctionG-protein coupled receptor resensitization-appreciating the balancing act of receptor function.Key role of ERK1/2 molecular scaffolds in heart pathology.Apelin receptor: its responsiveness to stretch mechanisms and its potential for cardiovascular therapy.Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation.Role of β-blocker therapy in pediatric heart failureExacerbated cardiac fibrosis induced by β-adrenergic activation in old mice due to decreased AMPK activity.New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
P2860
Q26771250-DF2B55FE-C8C7-4EE2-A106-EE08408A5F1DQ26785302-51A962C7-BDD0-4943-8B59-4E3CE52B1D7AQ28582124-0A8D7C0C-74B1-49AB-A398-99E21CF64A82Q28590516-9B7E068C-2F91-4454-B6C3-BF8E44B6FCDFQ33678921-ED7DBA91-E186-488F-AEBA-BBC87722BEDEQ34746623-A4869D76-2F34-4830-9265-DB2622C3EEFDQ35377780-A008CEE1-0940-4176-8250-0F1CD51DE404Q36363295-67B9A67A-9744-47A6-BB96-8A2716B8DFE9Q36381803-F6505D19-38A5-4E01-AEEE-B23F7B30CD79Q37102508-CDE57259-FDD7-40F6-9367-246A29FA7CE6Q37145670-4FFEB4E8-E156-4185-928F-0B58635D0CBAQ38018652-B1411BE4-E9CB-4534-B5A0-77AC27B7269FQ38093445-58916FAF-3915-4CFD-BE24-61F0428EEC41Q38209177-24B99CB0-2E61-4308-8916-E8CD11F0C1BEQ39156287-AF24530D-8174-4693-9DE4-065C3BF3D9AAQ42034500-3161CFFE-76E9-42F4-A310-16DDFF8A83DCQ51655884-64D787CB-6AAF-405A-AB96-71A8A3E2E051Q58790122-B8C94B03-502A-4CDA-9E6E-EC8111EAEE82
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beta-arrestin-mediated signaling in the heart.
@en
Beta-arrestin-mediated signaling in the heart.
@nl
type
label
Beta-arrestin-mediated signaling in the heart.
@en
Beta-arrestin-mediated signaling in the heart.
@nl
prefLabel
Beta-arrestin-mediated signaling in the heart.
@en
Beta-arrestin-mediated signaling in the heart.
@nl
P2093
P2860
P356
P1433
P1476
Beta-arrestin-mediated signaling in the heart.
@en
P2093
Douglas G Tilley
Howard A Rockman
Priyesh A Patel
P2860
P304
P356
10.1253/CIRCJ.CJ-08-0734
P577
2008-10-07T00:00:00Z